Demet Kartal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Demet Kartal has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Murat Borlu
Department of Dermatology Erciyes University Medical Faculty Kayseri Turkiye
6 shared publications - Salih Levent Cinar
Department of Dermatology Erciyes University Faculty of Medicine Kayseri Turkey
5 shared publications Murat Borlu
Dermatology and Venereology Department, Erciyes University Medical School, Kayseri, Türkiye
4 shared publicationsAyten Kesikoğlu
Department of Dermatology and Venereology, Faculty of Medicine, Erciyes University, Kayseri, Turkey
2 shared publicationsLevent Kartal
Department of Otorhinolaryngology - Kayseri Education and Research Hospital – Kayseri, Turkey
2 shared publicationsAtıl Avcı
1 shared publication
Latest Publications
- Open Access
- 3 March 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1531777
Regulation of DNA methylation in lesional tissue of children with atopic dermatitis
Background: Genetic and epigenetic mechanisms have been shown to play a role in the pathogenesis of atopic dermatitis (AD). However, the role of genes involved in the establishment of DNA methylation has not yet been demonstrated.Methods: A total of 15 pediatric patients with AD and 15 healthy volunteers were included in this study. The mRNA gene expression levels of eight different genes involved in the regulation of DNA methylation were examined in the blood and tissue samples.Results: The mRNA expression levels of DNMT3A genes were significantly increased, while the mRNA expression levels of DNMT3B, TET1, and TET2 genes were statistically significantly reduced in the lesional tissue of patients compared to the control group. It was observed that the mRNA expression levels of DNMT1, DNMT3A, and TET3 genes were increased, while the mRNA expression levels of DNMT3L and TET1 genes were found to be decreased in the blood of the patients.Conclusion: The results indicated that the DNA methylation pattern in the patients was hypermethylated, especially in the lesional tissue. The data obtained may contribute to the understanding of the epigenetic regulation of AD and aid in the development of new diagnostic and treatment options.
- 3 March 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 12, 1531777
Open AccessRegulation of DNA methylation in lesional tissue of children with atopic dermatitis
Background: Genetic and epigenetic mechanisms have been shown to play a role in the pathogenesis of atopic dermatitis (AD). However, the role of genes involved in the establishment of DNA methylation has not yet been demonstrated.Methods: A total of 15 pediatric patients with AD and 15 healthy volunteers were included in this study. The mRNA gene expression levels of eight different genes involved in the regulation of DNA methylation were examined in the blood and tissue samples.Results: The mRNA expression levels of DNMT3A genes were significantly increased, while the mRNA expression levels of DNMT3B, TET1, and TET2 genes were statistically significantly reduced in the lesional tissue of patients compared to the control group. It was observed that the mRNA expression levels of DNMT1, DNMT3A, and TET3 genes were increased, while the mRNA expression levels of DNMT3L and TET1 genes were found to be decreased in the blood of the patients.Conclusion: The results indicated that the DNA methylation pattern in the patients was hypermethylated, especially in the lesional tissue. The data obtained may contribute to the understanding of the epigenetic regulation of AD and aid in the development of new diagnostic and treatment options.
- Open Access
- 23 April 2024
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 15 (3) , 507-508
Juvenile Dermatomyositis Early Onset, Case Report
- 23 April 2024
- Published by Wolters Kluwer Health in Indian Dermatology Online Journal
- Vol. 15 (3) , 507-508
Open AccessJuvenile Dermatomyositis Early Onset, Case Report
- Open Access
- 28 September 2023
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1222126
Clinical effects of COVID-19 vaccines on chronic spontaneous urticaria patients: a study on two Turkish centers
Background: The relationship between CSU and vaccines is reported in the literature. The post-vaccine clinical effect of COVİD-19 vaccines on CSU patients is still unclear. we aimed to evaluate clinical effects of COVID-19 Vaccines on CSU patients.Materials and methods: CSU patients under treatment and follow-up in our outpatient clinic were evaluated retrospectively. To determine disease activity the urticaria activity score over seven days (UAS7) was used. The details of demographic information, CSU treatment, history of COVID-19 infection and exacerbation of urticaria during infection, COVID-19 vaccinations, type of vaccine, side effect reaction time after vaccination, hospital admission requirement were also assessed.Results: Total of 190 patients with a mean age of The mean age of patients was 41,7±14,0 years (range = 18–72) were enrooled. The patient sample consisted of 50 males and 140 females (male/female ratio 1:2.8). 181 (CoronaVac 77, Pfizer-BioNTech 104) patients were vaccinated. Urticarial exacerbation was occurred in 25 patients. The median UAS value was 5 before vaccination, it was 12 in patients with post-vaccine urticaria. Two patients had angioedema and one patient had anaphylaxis after vaccinated with Pfizer-BioNTech.Conclusion: COVID-19 vaccination in the CSU can be considered safe. Cases with urticarial exacerbation appear to be transient and can be managed by antihistamine and/or systemic steroid therapies. More extensive studies are needed for the relationship with CSU and post-coronavirus vaccination anaphylaxy.
- 28 September 2023
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 10, 1222126
Open AccessClinical effects of COVID-19 vaccines on chronic spontaneous urticaria patients: a study on two Turkish centers
Background: The relationship between CSU and vaccines is reported in the literature. The post-vaccine clinical effect of COVİD-19 vaccines on CSU patients is still unclear. we aimed to evaluate clinical effects of COVID-19 Vaccines on CSU patients.Materials and methods: CSU patients under treatment and follow-up in our outpatient clinic were evaluated retrospectively. To determine disease activity the urticaria activity score over seven days (UAS7) was used. The details of demographic information, CSU treatment, history of COVID-19 infection and exacerbation of urticaria during infection, COVID-19 vaccinations, type of vaccine, side effect reaction time after vaccination, hospital admission requirement were also assessed.Results: Total of 190 patients with a mean age of The mean age of patients was 41,7±14,0 years (range = 18–72) were enrooled. The patient sample consisted of 50 males and 140 females (male/female ratio 1:2.8). 181 (CoronaVac 77, Pfizer-BioNTech 104) patients were vaccinated. Urticarial exacerbation was occurred in 25 patients. The median UAS value was 5 before vaccination, it was 12 in patients with post-vaccine urticaria. Two patients had angioedema and one patient had anaphylaxis after vaccinated with Pfizer-BioNTech.Conclusion: COVID-19 vaccination in the CSU can be considered safe. Cases with urticarial exacerbation appear to be transient and can be managed by antihistamine and/or systemic steroid therapies. More extensive studies are needed for the relationship with CSU and post-coronavirus vaccination anaphylaxy.
- Open Access
- 12 September 2020
- Published by Springer Nature in Cureus
- Vol. 12 (9)
Coronavirus Disease 2019 (COVID-19) Accompanied by Maculopapular Rash: A Case Study
A new type of coronavirus (coronavirus disease 2019; COVID-19), which emerged in the People's Republic of China, spread all over the world over time and became a pandemic. Dermatological symptoms seen during the course of the disease have gained importance over time. Studies have shown that many dermatological findings such as erythematous rash, urticaria, pseudo-chilblain, maculopapular, livedo/necrosis, and vesicular lesions may accompany the disease. In this study, a 24-year-old female patient with maculopapular lesions who had no previous history of allergy or dermatological disease and regressed without any dermatological treatment is presented.
- 12 September 2020
- Published by Springer Nature in Cureus
- Vol. 12 (9)
Open AccessCoronavirus Disease 2019 (COVID-19) Accompanied by Maculopapular Rash: A Case Study
A new type of coronavirus (coronavirus disease 2019; COVID-19), which emerged in the People's Republic of China, spread all over the world over time and became a pandemic. Dermatological symptoms seen during the course of the disease have gained importance over time. Studies have shown that many dermatological findings such as erythematous rash, urticaria, pseudo-chilblain, maculopapular, livedo/necrosis, and vesicular lesions may accompany the disease. In this study, a 24-year-old female patient with maculopapular lesions who had no previous history of allergy or dermatological disease and regressed without any dermatological treatment is presented.
- Open Access
- 9 May 2018
- Published by IntechOpen
Dermatitis Herpetiformis
Dermatitis herpetiformis is an autoimmune skin disease, which is strongly related to coeliac disease. Moreover, some authors accept it as the skin manifestation of coeliac disease. It is a chronic, recurrent disease with polymorphic skin eruptions and pruritus. Dermatitis herpetiformis is a disease of the young adults mostly, but can be seen at any age. It is characterized by papules, vesicles, excoriations, and urticarial plaques clinically. Histopathological examination reveals subepidermal separation, and with this finding, it needs to be differentiated from linear IgA bullous dermatitis and bullous pemphigoid. In this case, direct immunofluorescence is helpful. Granular deposition of IgA is pathognomonic for dermatitis herpetiformis. Dermatitis herpetiformis can accompany other autoimmune disorders such as type I diabetes mellitus, thyroid diseases, vitiligo, and collagen tissue diseases. Dermatitis herpetiformis is, usually, successfully treated with dapsone and gluten-free diet.
- 9 May 2018
- Published by IntechOpen
Open AccessDermatitis Herpetiformis
Dermatitis herpetiformis is an autoimmune skin disease, which is strongly related to coeliac disease. Moreover, some authors accept it as the skin manifestation of coeliac disease. It is a chronic, recurrent disease with polymorphic skin eruptions and pruritus. Dermatitis herpetiformis is a disease of the young adults mostly, but can be seen at any age. It is characterized by papules, vesicles, excoriations, and urticarial plaques clinically. Histopathological examination reveals subepidermal separation, and with this finding, it needs to be differentiated from linear IgA bullous dermatitis and bullous pemphigoid. In this case, direct immunofluorescence is helpful. Granular deposition of IgA is pathognomonic for dermatitis herpetiformis. Dermatitis herpetiformis can accompany other autoimmune disorders such as type I diabetes mellitus, thyroid diseases, vitiligo, and collagen tissue diseases. Dermatitis herpetiformis is, usually, successfully treated with dapsone and gluten-free diet.
- Open Access
- 1 March 2017
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 92 (2) , 191-195
Effects of isotretinoin on the olfactory function in patients with acne
Keywords: Isotretinoin; Olfaction disorders; Smell
- 1 March 2017
- Published by FapUNIFESP (SciELO) in Anais Brasileiros de Dermatologia
- Vol. 92 (2) , 191-195
Open AccessEffects of isotretinoin on the olfactory function in patients with acne
Keywords: Isotretinoin; Olfaction disorders; Smell
- Open Access
- 10 January 2016
- Published by Sciencedomain International in International Journal of Medical and Pharmaceutical Case Reports
- Vol. 7 (2) , 1-3
Allergic Contact Dermatitis Caused by Both Eucalyptus Oil and Spruce Oil
Infantum cold® (Sedomed İlaç Pazarlama-Konya-Turkey) is an inhalant ointment that helps to relieve nasal congestion due to upper respiratory tract infections. It contains only eucalyptus oil and spruce oil. Although many reports present allergic contact dermatitis (ACD) due to eucalyptus oil and spruce oil separately there are no cases caused by both oil. We present a case of a pediatric patient who developed an ACD secondary to application of Infantum cold®. We believe that ACD due to eucalyptus oil and spruce oil might be more common than currently described in the literature. We encourage others to test with eucalyptus oil and spruce oil if there is clinical indication.
- 10 January 2016
- Published by Sciencedomain International in International Journal of Medical and Pharmaceutical Case Reports
- Vol. 7 (2) , 1-3
Open AccessAllergic Contact Dermatitis Caused by Both Eucalyptus Oil and Spruce Oil
Infantum cold® (Sedomed İlaç Pazarlama-Konya-Turkey) is an inhalant ointment that helps to relieve nasal congestion due to upper respiratory tract infections. It contains only eucalyptus oil and spruce oil. Although many reports present allergic contact dermatitis (ACD) due to eucalyptus oil and spruce oil separately there are no cases caused by both oil. We present a case of a pediatric patient who developed an ACD secondary to application of Infantum cold®. We believe that ACD due to eucalyptus oil and spruce oil might be more common than currently described in the literature. We encourage others to test with eucalyptus oil and spruce oil if there is clinical indication.
- Open Access
- 1 January 2016
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 28 (5) , 643-645
Cutaneous Amyloidoma: A Rare Case Report
Kartal D, et al. Ann Dermatol. 2016 Oct;28(5):643-645. https://doi.org/10.5021/ad.2016.28.5.643
- 1 January 2016
- Published by Korean Dermatological Association and The Korean Society for Investigative Dermatology in Annals of Dermatology
- Vol. 28 (5) , 643-645
Open AccessCutaneous Amyloidoma: A Rare Case Report
Kartal D, et al. Ann Dermatol. 2016 Oct;28(5):643-645. https://doi.org/10.5021/ad.2016.28.5.643
- Open Access
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 3 (3) , 232-234
Thyroid abnormalities in paediatric patients with vitiligo: retrospective study
Introduction : The association between vitiligo and thyroid disease is not fully investigated especially in paediatric patients. Aim : To determine the incidence of vitiligo and thyroid disorders in children. This is the first report from middle Anatolia and the second report from Turkey....
- 1 January 2016
- Published by Termedia Sp. z.o.o. in Advances in Dermatology and Allergology
- Vol. 3 (3) , 232-234
Open AccessThyroid abnormalities in paediatric patients with vitiligo: retrospective study
Introduction : The association between vitiligo and thyroid disease is not fully investigated especially in paediatric patients. Aim : To determine the incidence of vitiligo and thyroid disorders in children. This is the first report from middle Anatolia and the second report from Turkey....
- 1 January 2016
- Published by LookUs Bilisim A.S. in Kafkas Journal of Medical Sciences
- Vol. 6 (1) , 46-52
The skin findings of pregnant women and our treatment choices. A Turkish experience: a 5-year survey.
- 1 January 2016
- Published by LookUs Bilisim A.S. in Kafkas Journal of Medical Sciences
- Vol. 6 (1) , 46-52
The skin findings of pregnant women and our treatment choices. A Turkish experience: a 5-year survey.